Browsing “Press Releases | EVERSANA”

Mirum Pharmaceuticals Announces Partnership With EVERSANA to Support Launch and Commercialization of Maralixibat for Alagille Syndrome in the United States

Agreement outlines commercialization and distribution services to support patients diagnosed with Alagille syndrome FOSTER CITY, Calif. — Oct. 15, 2020– Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases, today announced it has partnered with EVERSANA™, a leading provider of commercial services to […]

Palette Life Sciences Announces Partnership Agreement With EVERSANA to Support US Commercialization of Solesta™

Agreement outlines commercialization and distribution services to enhance market access for patients diagnosed with fecal incontinence SANTA BARBARA, CALIF. AND STOCKHOLM – September 28, 2020 – Palette Life Sciences, a fully integrated life sciences company, today announced it has partnered with EVERSANA™, a leading provider of commercial services to the life science industry, to enhance […]

EVERSANA launches ACTICS by EVERSANA™, the technology-enabled solution combining predictive analytics integrated with real-time commercial services to drive next best action in the life science sector

CHICAGO – September 16, 2020 – EVERSANA™, the leading provider of global commercial services to the life sciences industry, today launched ACTICS by EVERSANA™, the technology-enabled solution to optimize end-to-end commercial success for life science companies. Combining the power of AI-driven predictive analytics with ready-to-deploy, real-time commercial services, ACTICS provides the cloud-based solution pharmaceutical innovators […]

EVERSANA™ expands pharmaceutical training and digital engagement capabilities with acquisition of Alkemy Partners

CHICAGO – September 9, 2020 – EVERSANA™, the leading provider of commercial services to the life science industry, today announced the acquisition of Alkemy Partners, a full-service field learning and development company committed to solving market access, sales and clinical engagement through training, content creation and digital solutions. The acquisition of the New Hampshire-based company […]

Evoke Pharma and EVERSANA Announce the Appointment of Christopher Quesenberry as Chief Commercial Officer for Gimoti™

Gimoti commercial launch on track for the fourth quarter of 2020 SOLANA BEACH, Calif. and CHICAGO, Aug. 25, 2020 – Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases and EVERSANA™, a leading provider of global commercial services to the life science industry, today announced that EVERSANA has […]

Zosano Pharma Announces Partnership Agreement with EVERSANA to Support the Launch and Commercialization of Qtrypta™

Agreement outlines commercialization and distribution execution strategy upon FDA approval EVERSANA to provide commercial services of approximately $250 million over 5 years FREMONT, Calif., August 6, 2020 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced it has partnered with EVERSANA, a leading provider of commercial services to the life science […]

EVERSANA™ and Havas Health & You announce exclusive strategic partnership, optimizing global data & analytics platform, expansive network reach and commercialization expertise for life sciences category

CHICAGO – July 30, 2020 – EVERSANA™, the leading provider of commercial services to the life science industry, and Havas Health & You (HH&Y), the world’s largest global health and wellness network, today announced an exclusive strategic partnership agreement, inclusive of data, analytics and predictive platforms, combined with commercialization services, to offer to health and […]

Vineti and EVERSANA™ form strategic alliance to advance patient-centered services and supply chain automation for regenerative medicine

Integrated Commercial Services and Personalized Therapy Management systems to seamlessly track product and patient journey SAN FRANCISCO, Calif. and CHICAGO, Illinois – July 29, 2020 – Vineti, the California-based company that offers a digital platform to enable broad access to advanced therapeutics, and EVERSANA™, a provider of global integrated commercial services to the life science […]

EVERSANA’s Data & Analytics platform to be used by ICER to conduct indirect treatment comparisons to support value assessments

CHICAGO – July 23, 2020 – EVERSANA™, the leading provider of global commercial services to the life sciences industry, today announced a partnership with the Institute for Clinical and Economic Review (ICER) to advance standards for the usage of transparent, replicable and robust indirect treatment comparisons in health technology assessments. ICER is an independent nonprofit […]

EVERSANA™ appoints Kelly Baker to Chief Financial Officer

Seasoned financial executive to shepherd global growth and scale of commercial service platform CHICAGO – May 4, 2020 – EVERSANA™, the leading independent provider of global commercial services to the life sciences industry, today announced the appointment of Kelly Baker to Chief Financial Officer (CFO). Baker will direct the company’s financial excellence and lead the […]